Insider Transactions in Q4 2025 at Viking Therapeutics, Inc. (VKTX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 28
2025
|
Marianna Mancini Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,185
-1.59%
|
$216,475
$35.0 P/Share
|
|
Oct 28
2025
|
Greg Zante Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,185
-3.44%
|
$216,475
$35.0 P/Share
|
|
Oct 28
2025
|
Brian Lian President & CEO |
SELL
Open market or private sale
|
Direct |
38,989
-1.59%
|
$1,364,615
$35.01 P/Share
|
|
Oct 27
2025
|
Marianna Mancini Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,117
+2.78%
|
-
|
|
Oct 27
2025
|
Greg Zante Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,117
+5.82%
|
-
|
|
Oct 27
2025
|
Brian Lian President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
70,084
+2.77%
|
-
|
|
Oct 27
2025
|
Charles A Rowland Jr |
SELL
Open market or private sale
|
Direct |
60,000
-66.67%
|
$2,100,000
$35.57 P/Share
|
|
Oct 27
2025
|
Charles A Rowland Jr |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+23.3%
|
$300,000
$5.05 P/Share
|